Mardia Samyoung Capillary Tubes Company Ltd (513544)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Mardia Samyoung's revenue was ₹24.8 Cr, and net profit ₹1.1 Cr (against a loss a year earlier); the operating margin was 5.7%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹24.8 | — | -59.4% |
| Operating profit | ₹1.4 | from loss | -21.1% |
| Net profit | ₹1.1 | from loss | -8.6% |
| EPS (₹) | 0.13 | from loss | -23.5% |
| Operating margin | 5.7% | — | — |
📢 Recent Corporate Announcements
Mardia Samyoung Capillary Tubes Company Ltd held a Board meeting on September 03, 2026, approving the notice for its 34th AGM scheduled on September 29, 2026. The Board recommended the appointment of M/s S K Bhavsar & Co. as Statutory Auditors and M/s Shekhawat & Associates as Secretarial Auditors, both for 5-year tenures (FY 2026-27 to FY 2030-31). Additionally, the Board approved shifting the company's registered office from Maharashtra to Gujarat, subject to shareholder and statutory approvals.
- 34th Annual General Meeting scheduled for Tuesday, September 29, 2026, at 2:00 PM IST
- Appointment of M/s S K Bhavsar & Co. as Statutory Auditors for 5 consecutive years (FY 2026-27 to FY 2030-31)
- Appointment of M/s Shekhawat & Associates as Secretarial Auditors for 5 consecutive years
- Approval of Registered Office relocation from the State of Maharashtra to the State of Gujarat
Mardia Samyoung Capillary Tubes Company Ltd has scheduled a Board of Directors meeting for September 3, 2026. The board will consider convening the forthcoming Annual General Meeting (AGM) and approving the Directors' Report for FY 2025-26. Additionally, the board will evaluate a proposal to shift the company's registered office from Maharashtra to Gujarat, which will be subject to shareholder and regulatory approvals.
- Board meeting scheduled for Thursday, September 03, 2026
- Proposal to shift registered office from Maharashtra to Gujarat under consideration
- Approval of AGM notice, date, venue, and agenda on the schedule
- Approval of Directors' Report for FY 2025-26 on the agenda
Mardia Samyoung Capillary Tubes Company Ltd has informed exchanges about the launch of its new functional website (www.mardiasygltd.com) pursuant to Regulation 46 of SEBI LODR Regulations. This follows the acquisition of the company as a going concern under a liquidation process. The company stated that it is in the process of populating the website with mandatory disclosures and information.
- New functional website launched at www.mardiasygltd.com pursuant to Regulation 46 of SEBI LODR
- Filing follows the acquisition of the company as a going concern under the liquidation process
- Intimation submitted to BSE on August 19, 2026 under scrip code 513544
Mardia Samyoung reported a net profit of Rs 1.05 Cr on revenue of Rs 24.84 Cr for the quarter ended June 30, 2026. However, the statutory auditor issued a severe 'Emphasis of Matter' stating they were unable to verify sales/purchase invoices, physical inventory, or the end-utilization of Rs 15.82 Cr raised via warrant conversion. Most critically, the company granted interest-free advances of Rs 22.84 Cr (approx. 24% of net worth) during the quarter without supporting documentation or clear business rationale. The company also appears to have shifted its primary business segment to 'Trading of Agriculture Product'.
- Revenue from operations reported at Rs 24.84 Cr for the quarter ended June 30, 2026.
- Net profit stood at Rs 1.05 Cr, a turnaround from a loss of Rs 0.23 Cr in the year-ago quarter.
- Raised Rs 15.82 Cr through the conversion of 1,17,15,000 warrants into equity shares.
- Auditor flagged Rs 22.84 Cr in interest-free advances given without documentation or business rationale.
- Auditor unable to verify physical inventory or sales/purchase invoices for the quarter.
Mardia Samyoung Capillary Tubes approved its unaudited standalone financial results for the quarter ended June 30, 2026, in a board meeting held on August 11, 2026. The company also announced a relocation of its corporate office from Gandhinagar to Ahmedabad (Thaltej) effective immediately. This follows a volatile period where revenue jumped from zero in early FY26 to Rs 61.12 Cr in Q4 FY26. Investors should remain cautious as promoter holding significantly dropped from 69.41% to 26.46% in the quarter ending March 2026.
- Board approved unaudited standalone financial results for the quarter ended June 30, 2026
- Corporate office shifted to Ahmedabad (Thaltej) from Gandhinagar effective August 11, 2026
- Board meeting concluded within 1 hour, starting at 08:00 PM and ending at 09:00 PM
- Promoter holding recently saw a sharp decline of 42.95% to reach 26.46% as of March 2026
Mardia Samyoung Capillary Tubes has scheduled a board meeting for August 11, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026. The company is coming off a high-growth period where FY26 revenue reached Rs 73.87 Cr compared to zero in FY25. However, investors should be aware of the significant promoter stake reduction from 69.41% in December 2025 to 26.46% in March 2026. The company maintains a small market cap of Rs 55 Cr with zero debt.
- Board meeting scheduled for August 11, 2026, to approve Q1 results
- Reviewing performance for the period ended June 30, 2026
- Company reported a significant revenue jump to Rs 61.12 Cr in the March 2026 quarter
- Promoter holding recently decreased to 26.46% from 69.41%
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
